0001628280-23-021962.txt : 20230613 0001628280-23-021962.hdr.sgml : 20230613 20230613164121 ACCESSION NUMBER: 0001628280-23-021962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230609 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Christopher Ryan CENTRAL INDEX KEY: 0001810417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 231011749 MAIL ADDRESS: STREET 1: C/O CERECOR INC. STREET 2: 400 E. PRATT STREET, SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wk-form4_1686688870.xml FORM 4 X0407 4 2023-06-09 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001810417 Sullivan Christopher Ryan C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-06-09 4 P 0 511 3.42 A 1262 D These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan. /s/ Jennifer Zoltoski, by Power of Attorney 2023-06-12